
pmid: 22537050
handle: 11380/764895
The patent claims peptidic/nonpeptidic inhibitors of the ghrelin receptor, the growth hormone secretagogue receptor (GHSR) 1A. Among these compounds, it was disclosed that the addition in some compounds of a GlyMetAla tripeptide at the N-terminus of the ghrelin peptide agonists converts them into ghrelin receptor antagonists. One of these peptides, among the few that have been studied in vivo, was shown to be able to reduce food intake and body weight gain in rats.
Molecular Structure, Transfection, Weight Gain, Ghrelin receptor antagonists; diabetes; obesity, Rats, Patents as Topic, Rats, Sprague-Dawley, Eating, Structure-Activity Relationship, HEK293 Cells, Hormone Antagonists, Drug Design, Animals, Humans, Female, Anti-Obesity Agents, Peptides, Receptors, Ghrelin
Molecular Structure, Transfection, Weight Gain, Ghrelin receptor antagonists; diabetes; obesity, Rats, Patents as Topic, Rats, Sprague-Dawley, Eating, Structure-Activity Relationship, HEK293 Cells, Hormone Antagonists, Drug Design, Animals, Humans, Female, Anti-Obesity Agents, Peptides, Receptors, Ghrelin
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 4 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
